BioCentury
ARTICLE | Clinical News

Second-generation calcimimetic: Partner Amgen Inc. began Phase II testing

October 12, 1998 7:00 AM UTC

NPS Pharmaceuticals Inc. (NPSP), Salt Lake City, Utah Product: Second-generation calcimimetic Indication: Treat primary hyperparathyroidism Status: Partner Amgen Inc. (AMGN, Thousand Oaks, Calif.) b...